Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Shares Outstanding (2021 - 2025)

Kezar Life Sciences' Shares Outstanding history spans 4 years, with the latest figure at $7.3 million for Q3 2024.

  • For Q3 2024, Shares Outstanding changed 0.37% year-over-year to $7.3 million; the TTM value through Sep 2024 reached $7.3 million, changed 0.37%, while the annual FY2023 figure was $7.3 million, 6.26% up from the prior year.
  • Shares Outstanding for Q3 2024 was $7.3 million at Kezar Life Sciences, roughly flat from $7.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $72.5 million in Q2 2023 and bottomed at $6.8 million in Q4 2022.
  • The 4-year median for Shares Outstanding is $48.1 million (2021), against an average of $38.9 million.
  • The largest annual shift saw Shares Outstanding soared 41.95% in 2022 before it plummeted 89.72% in 2024.
  • A 4-year view of Shares Outstanding shows it stood at $56.3 million in 2021, then crashed by 87.83% to $6.8 million in 2022, then rose by 6.26% to $7.3 million in 2023, then increased by 0.25% to $7.3 million in 2024.
  • Per Business Quant, the three most recent readings for KZR's Shares Outstanding are $7.3 million (Q3 2024), $72.9 million (Q2 2024), and $7.3 million (Q1 2024).